179
Views
4
CrossRef citations to date
0
Altmetric
Review

The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis

, , , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 79-91 | Published online: 28 Apr 2021

References

  • Smith V, Scirè CA, Talarico R, et al. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open. 2018;4(1):e000782.
  • Hughes M, Bruni C, Ruaro B, Confalonieri M, Matucci-Cerinic M, Bellando-Randone S. Digital ulcers in systemic sclerosis. Presse Med. 2021;50(1):104064.
  • Hughes M, Bruni C, Cuomo G, et al. The role of ultrasound in systemic sclerosis: on the cutting edge to foster clinical and research advancement. J Scleroderma Relat Disord. 2020.
  • Czirják L, Foeldvari I, Muller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology (Oxford). 2008;47(5):44–45.
  • Clements PJ, Hurwitz EL, Wong WK, et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum. 2000;43(11):2445–2454.
  • Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum. 2001;44(12):2828–2835.
  • Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum. 1990;33(8):1256–1263.
  • Ruaro B, Soldano S, Smith V, et al. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study. Rheumatol Int. 2019;39(8):1369–1376.
  • Cutolo M, Ruaro B, Montagna P, et al. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts. Arthritis Res Ther. 2018;20(1):77.
  • Wick G, Grundtman C, Mayerl C, et al. The immunology of fibrosis. Annu Rev Immunol. 2013;31(3):107–135.
  • Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nature Rev Rheumatol. 2012;8(1):42–54.
  • Cutolo M, Damjanov N, Ruaro B, Zekovic A, Smith V. Imaging of connective tissue diseases: beyond visceral organ imaging? Best Pract Res Clin Rheumatol. 2016;30(4):670–687.
  • Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum. 1979;22(2):130–140.
  • LeRoy EC, Meedsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573–1576.
  • Khanna D, Furst DE, Clements PJ, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2(1):11–18.
  • Kaldas M, Khanna PP, Furst DE, et al. Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis-assessment of individual body sites in two large randomized controlled trials. Rheumatology. 2009;48(9):1143–1146.
  • Czirják L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis. 2007;66(7):966–999.
  • Kaloudi O, Bandinelli F, Filippucci E, et al. High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis. 2010;69(6):1140–1143.
  • Moore TL, Lunt M, McManus B, Anderson ME, Herrick AL. Seventeen-point dermal ultrasound scoring system – a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology. 2003;42(12):1559–1563.
  • Sulli A, Ruaro B, Alessandri A, et al. Correlation between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients. Ann Rheum Dis. 2014;73(1):247–251.
  • Hesselstrand R, Scheja A, Wildt M, Akesson A. High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Rheumatology. 2008;47(1):84–87.
  • Alexander H, Miller DL. Determining skin thickness with pulsed ultrasound. J Invest Dermatol. 1979;72(1):17–19.
  • Santiago T, Santiago M, Ruaro B, Salvador MJ, Cutolo M, da Silva JAP. Ultrasonography for the assessment of skin in systemic sclerosis: a systematic review. Arthritis Care Res (Hoboken). 2019;71(4):563–574.
  • Ruaro B, Sakellariou G, Cutolo M, Iagnocco A. Well-trained sonographers are worth their weight in gold: ultrasound in systemic sclerosis. Rheumatology (Oxford). 2018;57(11):1883–1884.
  • Santiago T, Ruaro B, Cutolo M, Santiago M, Salvador MJ, da Silva JAP. Has the role of skin ultrasound for Systemic sclerosis been defined? Arthritis Care Res (Hoboken). 2019;71:695–696.
  • Abignano G, Del Galdo F. Quantitating skin fibrosis: innovative strategies and their clinical implication. Curr Rheumatol Rep. 2014;16(3):404.
  • Delle Sedie A, Riente L. Ultrasound in connective tissue diseases. Clin Exp Rheumatol. 2014;32(80):S53–60.
  • Ihn H, Shimozuma M, Fujimoto M, et al. Ultrasound measurement of skin thickness in systemic sclerosis. Br J Rheumatol. 1995;34(6):535–538.
  • Ruaro B, Sulli A, Bernero E, Cimmino MA, Paolino S, Cutolo M. Identification of subclinical skin involvement by high frequency ultrasound in systemic sclerosis patients. Arthritis Rheumatol. 2015;67(10):234.
  • Sulli A, Ruaro B, Smith V, et al. Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. Arthritis Res Ther. 2017;19(1):61.
  • Ruaro B, Sulli A, Pizzorni C, et al. Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients. Microvasc Res. 2018;115(3):28–33.
  • Ruaro B, Pizzorni C, Paolino S, et al. Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. Microvasc Res. 2019;125(4):103874.
  • Ruaro B, Sulli A, Smith V, et al. The impact of transducer frequency in ultrasound evaluation of subclinical skin involvement in limited cutaneous systemic sclerosis patients. Clin Exp Rheumatol. 2019;119(4):147–148.
  • Porta F, Kaloudi O, Garzitto A, et al. High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma. Modern Rheumatology. 2014;24(5):869–873.
  • Hoffmann K, Gerbaulet U, El-Gammal S, Altmeyer P. 20-MHz B-mode ultrasound in monitoring the course of localized scleroderma (morphea). Acta Derm Venereol Suppl (Stockh). 1991;164(3):3–16.
  • Cosnes A, Anglade MC, Revuz J, Radier C. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol. 2003;148(7):724–729.
  • Li SC, Liebling MS, Haines KA, et al. Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2011;63(5):735–1342.
  • Iagnocco A, Kaloudi O, Perella C, et al. Ultrasound elastography assessment of skin involvement in systemic sclerosis: lights and shadows. J Rheumatol. 2010;37(8):1688.
  • Di Geso L, Filippucci E, Girolimetti R, et al. Reliability of ultrasound measurements of dermal thickness at digits in systemic sclerosis: role of elastosonography. Clin Exp Rheumatol. 2011;29(6):926–932.
  • Ophir J, Cespedes I, Ponnekanti H, Hazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging. 1991;13(2):111–134.
  • Suliman YA, Kafaja S, Fitzgerald J, et al. Ultrasound characterization of cutaneous ulcers in systemic sclerosis. Clin Rheumatol. 2018;37(6):1555–1561.
  • Li H, Furst DE, Jin H, et al. High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference. Arthritis Res Ther. 2018;20(1):181.
  • Naredo E, Pascau J, Damjanov N, et al. Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: a preliminary report. Rheumatology (Oxford). 2020;59(7):1671–1678.
  • Chen C, Cheng Y, Zhu X, et al. Ultrasound assessment of skin thickness and stiffness: the correlation with histology and clinical score in systemic sclerosis. Arthritis Res Ther. 2020;22(1):197.
  • Arisi M, Lorenzi L, Incardona P, et al. Clinical, histological and high-frequency ultrasonographic evaluation (50 MHz) of morphoea treated with ultraviolet A1 phototherapy. Clin Exp Dermatol. 2019;44(3):270–276.
  • Cosnes A, Anglade MC, Revuz J, et al. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol. 2003;148(4):724–729.
  • Florez-Pollack S, Kunzler E, Jacobe T. H. Morphea: current concepts. Clin Dermatol. 2018;36(4):475–486.
  • Murray AK, Moore TL, Manning JB, et al. Non-invasive imaging of localised scleroderma for assessment of skin blood flow and structure. Acta Derm Venereol. 2016;96(5):641–644.
  • Nezafati KA, Cayce RL, Susa JS, et al. 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma). Arch Dermatol. 2011;147:1112–1115.
  • Pérez M, Zuccaro J, Mohanta A, et al. Feasibility of using elastography ultrasound in pediatric localized scleroderma (Morphea). Ultrasound Med Biol. 2020;46(12):3218–3227.
  • Ranosz-Janicka I, Lis-święty A, Skrzypek-Salamon A, et al. An extended high frequency ultrasound protocol for assessing and quantifying of inflammation and fibrosis in localized scleroderma. Skin Res Technol. 2019;25(3):359–366.
  • Weibel L, Theiler M, Howell KJ, et al. Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging. J Eur Acad Dermatol Venereol. 2020;34(7):1609–1616.
  • Wortsman X, Wortsman J, Sazunic I, Carreno L. Activity assessment in morphea Using color Doppler ultrasound. J Am Acad Dermatol. 2011;65:942–948.
  • Cannaò PM, Vinci V, Caviggioli F, et al. Technical feasibility of real-time elastography to assess the peri-oral region in patients affected by systemic sclerosis. J Ultrasound. 2014;17(4):265–269.
  • Çildağ S, Çildağ MB. The relationship between the degree of skin fibrosis by sonoelastography and the degree of pulmonary involvement in scleroderma. Turk J Med Sci. 2017;47(5):1555–1559.
  • Hou Y, Zhu QL, Liu H, et al. A preliminary study of acoustic radiation force impulse quantification for the assessment of skin in diffuse cutaneous systemic sclerosis. J Rheumatol. 2015;42(3):449–455.
  • Santiago T, Alcacer-Pitarch B, Salvador MJ, Del Galdo F, Redmond AC, da Silva JA. A preliminary study using virtual touch imaging and quantification for the assessment of Skin stiffness in systemic sclerosis. Clin Exp Rheumatol. 2016;Suppl 100(5):137–141.
  • Liu H, Hou Y, Zhu QL, et al. A preliminary study of skin ultrasound in diffuse cutaneous systemic sclerosis: does skin echogenicity matter? PLoS One. 2017;12(3):e0174481.
  • Yang Y, Wang L, Yan F, et al. Determination of normal skin elasticity by using real‐time shear wave elastography. J Ultrasound Med. 2018;37:2507–2516.
  • Sobolewski P, Maślińska M, Zakrzewski J, et al. Applicability of shear wave elastography for the evaluation of skin strain in systemic sclerosis. Rheumatol Int. 2020;40:737–745.
  • Flower VA, Barratt SL, Hart DJ, et al. High frequency ultrasound assessment of systemic sclerosis skin involvement: intra-observer repeatability and relationship with clinician assessment and dermal collagen content. J Rheumatol. 2020;1:jrheum.200234.
  • Santiago T, Santiago M, Coutinho M, Salvador MJ, Da Silva JAP. How much of skin improvement over time in systemic sclerosis is due to normal ageing? A prospective study with shear-wave elastography. Arthritis Res Ther. 2020;22(1):50.
  • Hughes M, Moore T, Manning J, Dinsdale G, Herrick AL, Murray A. A pilot study using high-frequency ultrasound to measure digital ulcers: a possible outcome measure in systemic sclerosis clinical trials? Clin Exp Rheumatol. 2017;35 Suppl 106(4):218–219.
  • Li W, Frech TM. The critical need for accurately defining digital ulcers in scleroderma. J Scleroderma Relat Disord. 2017;2(2):69–71.
  • Hughes M, Roberts C, Tracey A, Dinsdale G, Murray A, Herrick AL. Does the clinical context improve the reliability of rheumatologists grading digital ulcers in systemic sclerosis? Arthritis Care Res (Hoboken). 2016;68(9):1340–1345.
  • Hughes M, Tracey A, Bhushan M, et al. Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: a challenge for clinical trial design. J Scleroderma Relat Disord. 2018;3(2):170–174.
  • Frech T, Pierce J, Stoddard G, McNeill C, Radic M, Reems J. Amniotic membrane dressings provide an effective treatment for systemic sclerosis digital ulcers. Arthritis Rheumatol. 2019;71(suppl):10.
  • Hughes M. Response to ‘Ultrasound characterization of cutaneous ulcers in systemic sclerosis’. Clin Rheumatol. 2018;37(7):2013.